science_technology_and_other_research_and_development · DOD-AMRAA

DoW Arthritis Clinical Research Award

Defense Health Agency Contracting Activity - DHACA · HT942526ATRPCRA

61 days left

Total Program Funding

$7.2M

Expected Awards

Deadline

October 22, 2026

GRANTQUICK SUMMARYPlain-English Overview

DoW Arthritis Clinical Research Award. Defense Health Agency Contracting Activity - DHACA. Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize... $7,150,000 total program funding; ~4 awards expected.

Who Should Apply

Unrestricted (any eligible entity)

Who Should NOT Apply

Few restrictions — most eligible entities can apply

Key Requirements (Plain English)

•Deadline: 2026-10-22

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is encouraged.

Applications must address one of two FY26 ATRP CRA Focus Areas: Prevention and Early Diagnosis, or Treatment and Mitigation of Disease Progression/Burden.

Distinctive Features: The FY26 ATRP CRA offers funding for two research levels. It is the responsibility of the applicant to select the level that aligns with the scope of the proposed research.

• Research Level 1: Applications proposing clinical research or early-phase/pilot clinical trials, to include new or emerging research that is not ready for a full-scale randomized controlled clinical trial.

• Research Level 2: Applications proposing a full-scale clinical trial.

Applications should include a community collaborator (e.g., patient/care partner, community-based organization consultant) who will provide advice and consultation during study design and throughout study planning and implementation. The ATRP encourages a community collaborator for Research Level 1 applications and requires a community collaborator for Research Level 2 applications.

Preliminary and/or published data are required.